Intracellular trafficking of HIV-1 Gag: How Gag interacts with cell membranes and makes viral particles

AIDS Reviews

Volumn 7, Issue 2, 2005, Pages 84-91

  Resh, Marilyn D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Gag; HIV 1; Membrane targeting; Multivesicular bodies; Rafts; Trafficking

Indexed keywords

FATTY ACID; GAG PROTEIN; MYRISTIC ACID; POLYPROTEIN;

BILAYER MEMBRANE; CELL MEMBRANE; ENDOCYTOSIS; ENDOSOME; EXOCYTOSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRACELLULAR TRANSPORT; LENTIVIRINAE; MULTIVESICULAR BODY; MYRISTYLATION; NONHUMAN; POLYSOME; PROTEIN ASSEMBLY; PROTEIN LIPID INTERACTION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RETROVIRUS; REVIEW; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS PARTICLE;

CELL MEMBRANE; GENE PRODUCTS, GAG; HIV-1; HUMANS; PROTEIN BINDING; PROTEIN TRANSPORT; VIRION; VIRUS REPLICATION;

EID: 23144434990     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Freed E. HIV-1 Gag Proteins: Diverse Functions in the Virus Life Cycle. Virology 1988;251:1-15.
2. Garnier L, Bowzard J, Wills J. (1998). Recent advances and remaining problems in HIV assembly. AIDS 1988;12 (suppl A):S5-S16.
3. Gottlinger H. The HIV-1 Assembly machine. AIDS 2001;15:S13-S20.
4. Resh M. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta 1999;1451:1-16.
5. Maurer-Stroh S, Eisenhaber B, Eisenhaber F. N-terminal N-myristoylation of proteins: prediction of substrate proteins from amino acid sequence. J Mol Biol 2002;317:541-57.
6. Gottlinger H, Sodroski J, Haseltine W. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of HIV type 1. Proc Natl Acad Sci USA 1989;86:5781-5.
7. Bryant M, Ratner L. Myristoylation-dependent replication and assembly of HIV 1. Proc Natl Acad Sci USA 1990;87:523-7.
8. Garber E, Cross F, Hanafusa H. Processing of p60v-src to its Myristylated Membrane-Bound Form. Mol Cell Biol 1985;5:2781-8.
9. Kamps M, Buss J, Sefton B. Mutation of NH2-terminal Glycine of p60src Prevents Both Myristoylation and Morphological Transformation. Proc Natl Acad Sci USA 1985;82:4625-8.
10. Peitzsch R, McLaughlin S. Binding of Acylated Peptides and Fatty Acids to Phospholipid Vesicles: Pertinence to Myristoylated Proteins. Biochemistry 1993;32:10436-43.
11. Sigal C, Zhou W, Buser C, McLaughlin S, Resh M. The N-terminal Basic Residues of Src Mediate Membrane Binding through Electrostatic Interaction with Acidic Phospholipids. Proc Natl Acad Sci USA 1994;91:12253-7.
12. Resh M. Myristylation and Palmitylation of Src Family Members: The Fats of the Matter. Cell 1994;76:411-3.
13. Zhou W, Parent L, Wills J, Resh M. Identification of a Membrane Binding Domain within the Amino-Terminal Region of HIV Type 1 Gag Protein Which Interacts with Acidic Phospholipids. J Virol 1994;68:2556-69.
14. Garnier L, Ratner L, Rovinski B, Cao S, Wills J. Particle Size Determinants in the HIV Type 1 Gag Protein. J Virol 1988;72:4667-77.
15. Massiah M, Starich M, Paschall C, Summers M, Christensen A, Sundquist W. Three dimensional Structure of the HIV Type 1 Matrix Protein. J Mol Biol 1994;244:198-223.
16. Matthews S, Barlow P, Boyd J, et al. Structural similarity between the p17 matrix protein of HIV-1 and interferon-gamma. Nature 1994;370:666-8.
17. Hill C, Worthylake D, Bancroft D, Christensen A, Sundquist W. Crystal structures of the trimeric HIV type 1 matrix protein: implications for membrane association and assembly. Proc Natl Acad Sci USA 1996;93:3099-104.
18. Zhou W, Resh M. Differential Membrane Binding of the HIV Type 1 Matrix Protein. J Virol 1996;70:8540-8.
19. Spearman P, Horton R, Ratner L, Kuli-Zade I. Membrane Binding of HIV Type 1 Matrix Protein In Vivo Supports a Conformational Myristyl Switch Mechanism. J Virol 1997;71:6582-92.
20. Hermida-Matsumoto L, Rash M. HIV-1 Protease Triggers a Myristoyl Switch that Modulates Membrane Binding of Pr55gag and p17MA. J Virol 1999;73:1902-8.
21. Reil H, Bukovsky A, Gelderblom H, Gottlinger H. Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J 1988;17:2699-707.
22. Ono A, Freed E. Binding of HIV Type 1 Gag to Membrane: Role of the Matrix Amino Terminus. J Virol 1999;73:4136-44.
23. Paillart J, Gottlinger H. Opposing Effects of HIV Type 1 Matrix Mutations Support a Myristyl Switch Model of Gag Membrane Targeting. J Virol 1999;73:2604-12.
24. Resh M. A myristoyl switch regulates membrane binding of HIV-1 Gag. Proc Natl Acad Sci USA 2004;101:417-8.
25. Tang C, Loeliger E, Luncsford P, Kindle I, Beckett D, Summers M. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc Natl Acad Sci USA 2004;101:517-22.
26. Wu Z, Alexandratos J, Ericksen B, Lubkowski J, Gallo R, Lu W. Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation. Proc Natl Acad Sci USA 2004;101:11587-92.
27. Cimarelli A, Sandin S, Hoglund S, Luban J. Basic residues in HIV type 1 nucleocapsid promote virion assembly via interaction with RNA. J Virol 2000;74:3046-57.
28. Burniston M, Cimarelli A, Colgan J, Curtis S, Luban J. HIV type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein. J Virol 1999;73:8527-40.
29. Ono A, Demirov D, Freed E. Relationship between HIV type 1 gag multimerization and membrane binding. J Virol 2000;74:5142-50.
30. Perez-Caballero D, Hatziioannou T, Martin-Serrano J, Bieniasz P. HIV type 1 matrix inhibits and confers cooperativity on gag precursor-membrane interactions. J Virol 2004;78:9560-3.
31. Sandefur S, Varthakavi V, Spearman P. The 1 Domain Is Required for Efficient Plasma Membrane Binding of HIV Type 1 Pr55gag. J Virol 1998;72:2723-32.
32. Sandefur S, Smith R, Varthakavi V, Spearman P. Mapping and characterization of the N-terminal I domain of HIV type 1 Pr55(Gag). J Virol 2000;74:7238-49.
33. Tritel M, Resh M. Kinetic Analysis of HIV-1 Assembly Reveals the Presence of Sequential Intermediates. J Virol 2000;74:5845-55.
34. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997;387:569-72.
35. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000;1:31-9.
36. Nguyen D, Hildreth J. Evidence for Budding of HIV Type 1 Selectively from Glycolipid-Enriched Membrane Lipid Rafts. J Virol 2000;74:3264-72.
37. Lindwasser O, Resh M. Multimerization of HIV type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J Virol 2001;75:7913-24.
38. Ono A, Freed E. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci USA 2001;98:13925-30.
39. Ding L, Derdowski A, Wang J, Spearman P. Independent segregation of HIV type 1 Gag protein complexes and lipid rafts. J Virol 2003;77:1916-26.
40. Holm K, Weclewicz K, Hewson R, Suomalainen M. HIV type 1 assembly and lipid rafts: Pr55(gag) associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100. J Virol 2003;77:4805-17.
41. Lindwasser O, Resh M. Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding. Proc Natl Acad Sci USA 2002;99:13037-42.
42. Aloia R, Tian H, Jensen F. Lipid composition and fluidity of the HIV envelope and host cell plasma membranes. Proc Natl Acad Sci USA 1993;90:5181-5.
43. Liao Z, Cimakasky L, Hampton R, Nguyen D, Hildreth J. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retroviruses 2001;17:1009-19.
44. Guyader M, Kiyokawa E, Abrami L, Turelli P, Trono D. Role for HIV type 1 membrane cholesterol in viral internalization. J Virol 2002;76:10356-64.
45. Viard M, Parolini I, Sargiacomo M, et al. Role of cholesterol in HIV type 1 envelope protein-mediated fusion with host cells. J Virol 2002;76:11584-95.
46. Campbell S, Crowe S, Mak J. Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. AIDS 2002;16:2253-61.
47. Graham D, Chertova E, Hilburn J, Arthur L, Hildreth J. Cholesterol depletion of HIV type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts. J Virol 2003;77:8237-48.
48. Scheiffele P, Rietveld A, Wilk T, Simons K. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J Biol Chem 1999;274:2038-44.
49. Zhang J, Pekosz A, Lamb R. Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. J Virol 2000;74:4634-44.
50. Manie SN, Debreyne S, Vincent S, Gerlier D. Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly. J Virol 2000;74:305-11.
51. Bavari S, Bosio C, Wiegand E, et al. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 2002;195:593-602.
52. Suomalainen M. Lipid rafts and assembly of enveloped viruses. Traffic 2002;3:705-9.
53. Freed E. The HIV-TSG101 interface: recent advances in a budding field. Trends Microbiol 2003;11:56-9.
54. Pornillos O, Garrus J, Sundquist W. Mechanisms of enveloped RNA virus budding. Trends Cell Biol 2002;12:569-79.
55. Kikonyogo A, Bouamr F, Vana M, et al. Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc Natl Acad Sci USA 2001;98:11199-204.
56. VerPlank L, Bouamr F, LaGrassa T, et al. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci USA 2001;98:7724-9.
57. Garrus J, von Schwedler U, Pornillos O, et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001;107:55-65.
58. Timmins J, Schoehn G, Ricard-Blum S, et al. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J Mol Biol 2003;326:493-502.
59. Demirov D, Ono A, Orenstein J, Freed E. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc Natl Acad Sci USA 2002;99:955-60.
60. Martin-Serrano J, Zang T, Bieniasz P. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med 2001;7:1313-9.
61. Katzmann D, Odorizzi G, Emr S. Receptor downregulation and multivesicular-body sorting. Nat Rev Mol Cell Biol 2002;3:893-905.
62. Babst M, Odorizzi G, Estepa E, Emr S. Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic 2000;1:248-58.
63. Katzmann D, Babst M, Emr S. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 2001; 106:145-55.
64. Patnaik A, Chau V, Wills J. Ubiquitin is part of the retrovirus budding machinery. Proc Natl Acad Sci USA 2000;97:13069-74.
65. Goila-Gaur R, Demirov D, Orenstein J, Ono A, Freed E. Defects in HIV budding and endosomal sorting induced by TSG101 overexpression. J Virol 2003;77:6507-19.
66. Martin-Serrano J, Zang T, Bieniasz P. Role of ESCRT-I in retroviral budding. J Virol 2003;77:4794-4804.
67. von Schwedler U, Stuchell M, Muller B, et al. The protein network of HIV budding. Cell 2003;114:701-13.
68. Strack B, Calistri A, Craig S, Popova E, Gottlinger H. AIP1/ALIX is a binding partner for HIV-1 p6 and EAV p9 functioning in virus budding. Cell 2003;114;689-99.
69. Hermida-Matsumoto L, Resh M. Localization of HIV-1 Gag and Env at the Plasma Membrane by Confocal Imaging. J Virol 2000;74:8670-9.
70. Goff A, Ehrlich L, Cohen S, Carter C. Tsg101 control of HIV type 1 Gag trafficking and release. J Virol 2003;77:9173-82.
71. Raposo G, Moore M, Innes D, et al. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 2002;3:718-29.
72. Pelchen-Matthews A, Kramer B, Marsh M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol 2003;162:443-55.
73. Ono A, Freed E. Cell-type-dependent targeting of HIV type 1 assembly to the plasma membrane and the multivesicular body. J Virol 2004;78:1552-63.
74. Nydegger S, Foti M, Derdowski A, Spearman P, Thali M. HIV-1 egress is gated through late endosomal membranes. Traffic 2003;4:902-10.
75. Sharer N, Lehmann M, Jimenez-Soto L, et al. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 2003;4:785-801.
76. Perlman M, Resh M. Identification of a calcium-dependent virus assembly pathway for HIV-1 Gag. J. Cell Biol 2005, under revision.
77. Basyuk E, Galli T, Mougel M, Blanchard J, Sitbon M, Bertrand E. Retroviral genomic RNAs are transported to the plasma membrane by endosomal vesicles. Dev Cell 2003;5:161-74.
78. Blot V, Perugi F, Gay B, et al. Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding. J Cell Sci 2004;117:2357-67.
79. Kolesnikova L, Berghofer B, Bamberg S, Becker S. Multivesicular bodies as a platform for formation of the Marburg virus envelope. J Virol 2004;78:12277-87.
80. Sfakianos J, Hunter E. M-PMV capsid transport is mediated by Env/Gag interactions at the pericentriolar recycling endosome. Traffic 2003;4:671-80.
81. Ono A, Orenstein J, Freed E. Role of the Gag matrix domain in targeting HIV type 1 assembly. J Virol 2000;74:2855-66.
82. Lindwasser O, Resh M. HIV type 1 Gag contains a dileucine-like motif that regulates association with multivesicular bodies. J Virol 2004;78:6013-23.
83. Ono A, Ablan S, Lockett S, Nagashima K, Freed E. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc Natl Acad Sci USA 2004;101:14889-94.
84. Campbell S, Fisher R, Towler E, et al. Modulation of HIV-like particle assembly in vitro by inositol phosphates. Proc Natl Acad Sci USA 2001;98:10875-9.
85. Dong X, Li H, Derdowski A, et al. AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell 2005;120:663-74.
86. Dell'Angelica E, Shotelersuk V, Aguilar R, Gahl W, Bonifacino J. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell 1999;3:11-21.
87. Alroy I, Tuvia S, Greener T, et al. The trans-Golgi network-associated human ubiquitin-protein ligase POSH is essential for HIV type 1 production. Proc Natl Acad Sci USA 2005;102:1478-83.
88. Bukrinsky M, Haggerty S, Dempsey M, et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 1993;365:666-9.
89. Stevenson M. Portals of entry: uncovering HIV nuclear transport pathways. Trends Cell Biol 1996;6:9-15.
90. Fouchier R, Meyer B, Simon JHM, Fischer U, Malim M. HIV-1 infection of non-dividing cells: evidence that the amino terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J 1997;16:4531-9.
91. Freed E, Englund G, Martin M. Role of the Basic Domain of HIV-1 Matrix in Macrophage Infection. J Virol 1995;69:3949-54.
92. Dupont S, Sharova N, DeHoratius C, et al. A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature 1999;402:681-68.
93. Scheifele L, Garbitt R, Rhoads J, Parent L. Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein. Proc Natl Acad Sci USA 2002;99:3944-394.